Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2015, Article ID 276815, 9 pages
Research Article

Serum Markers in Rheumatoid Arthritis: A Longitudinal Study of Patients Undergoing Infliximab Treatment

1Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, 5020 Bergen, Norway
2Department of Rheumatology, Haukeland University Hospital, University of Bergen, 5020 Bergen, Norway

Received 18 September 2015; Revised 30 October 2015; Accepted 30 November 2015

Academic Editor: Bruce M. Rothschild

Copyright © 2015 Oddgeir Selaas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

Additional results are presented in the supplementary material. Distribution of ESR and CRP by gender and age (Supplementary Table 1) and frequencies of anti-CCP and rheumatoid factor (Supplementary Table 2). The clinical assessment of the RA patients (SWJ28, TEN28, ESR, CRP, MDGA-VAS and PGA-VAS) during the study (Supplementary figure 1). The RA patients grouped by disease activity (Supplementary figure 2) and the serum IgG-RF and anti-CCP titers during the study (Supplementary figure 3).

  1. Supplementary Material